Regulatory Strategy
A strong regulatory strategy drives successful drug development. It shapes the development path and determines the time, cost, and data required for approval.
We partner with you to reduce risk and optimize your program from early stage through non-clinical development to approval and beyond—helping you make the right decisions at the right time and increasing your chances of success.
Regulatory Affairs & Strategic Advice
Successful drug development depends on using time and resources effectively. We support your program from early research through clinical development and beyond, helping you plan ahead, meet regulatory expectations, and avoid delays. Our focus is simple: enable better decisions, faster progress, and a smoother path to approval.
Regulatory Strategy & Roadmap to Market Authorisation
We guide the development of your Target Product Profile (TPP), non-clinical and CMC plans, milestone plans, and overall regulatory roadmap. We identify key regulatory activities and relevant incentives to strengthen your product’s path to approval and maximize its chances of success.
Authority Interactions
Engaging with regulatory authorities is critical to development success.
We support and lead interactions such as scientific advice meetings and FDA meetings. We combine global regulatory expertise with strong project management to help your team address key challenges and make the relevant decisions based on the authorities feedback.
Regulatory Writing & Project Management
We provide expert support in preparing high-quality regulatory documents and managing submissions across all stages of development.
This includes clinical trial applications (CTA, IND), pediatric plans, regulatory designations (e.g. orphan drug, accelerated pathways), and marketing authorisation applications (MAA, NDA, BLA).
